Free Trial

Entera Bio (ENTX) Earnings Date, Estimates & Call Transcripts

Entera Bio logo
$2.51 +0.16 (+6.81%)
As of 10:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Entera Bio Earnings Summary

Upcoming
Earnings Date
May. 9Before Market OpensEstimated
Consensus EPS
(Mar. 28)
-$0.08
Actual EPS
(Mar. 28)
-$0.06 Beat By $0.02
Actual Revenue
(Mar. 28)
$0.04M

Entera Bio released Q4 2024 earnings on March 28, 2025, reporting an EPS of -$0.06, which topped analysts' consensus estimates of -$0.08 by $0.02. Quarterly revenue was reported to be $0.04 million, below the consensus estimate of $0.04 million. With a trailing EPS of -$0.25, Entera Bio's earnings are expected to decrease next year, from ($0.28) to ($0.55) per share.

Q4 2024 Earnings Resources

ENTX Upcoming Earnings

Entera Bio's Q1 2025 earnings is scheduled for Friday, May 9, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Entera Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Entera Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ENTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Entera Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.07-$0.07-$0.07
Q2 20251-$0.11-$0.11-$0.11
Q3 20251-$0.16-$0.16-$0.16
Q4 20251-$0.20-$0.20-$0.20
FY 20254($0.54)($0.54)($0.54)

Entera Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/9/2025
(Estimated)
-------
3/28/2025Q4 2024-$0.08-$0.06+$0.02-$0.06$0.04M$0.04M
8/9/2024--$0.06-$0.06--$0.06-$0.06M
5/10/2024Q1 2024-$0.06-$0.05+$0.01-$0.05--
3/8/2024Q4 2023-$0.08-$0.07+$0.01-$0.07--
11/14/2023Q3 2023-$0.09-$0.08+$0.01-$0.08--
8/11/2023Q2 2023-$0.07-$0.08 -$0.01-$0.08--
5/5/2023Q1 2023-$0.12-$0.08+$0.04-$0.08--

Entera Bio Earnings - Frequently Asked Questions

Entera Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based off last year's report dates. Learn more on ENTX's earnings history.

In the previous quarter, Entera Bio (NASDAQ:ENTX) reported ($0.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.02. Learn more on analysts' earnings estimate vs. ENTX's actual earnings.

Entera Bio (NASDAQ:ENTX) has a recorded annual revenue of $181,000.00.

Entera Bio (NASDAQ:ENTX) has a recorded net income of -$8.89 million. ENTX has generated -$0.25 earnings per share over the last four quarters.

Entera Bio's earnings are expected to decrease from ($0.28) per share to ($0.55) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ENTX) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners